http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015167567-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd640137625dcf55e6953e0cab81efe |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2259a86b060b1cf19dc2fad5c99388ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537fbfcbf986ebad2fb3a05d53d7fa94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b74ef88ddd123a4192fa04387c6086c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_913a6a6c57993cf2f895c1413a3191fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2164eebf9fc9227cc787d6b0d2dce3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98383b25ad5165c2cb6b9496c0372a67 |
| publicationDate | 2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015167567-A1 |
| titleOfInvention | Stat3 inhibitors for treatment of hyperglycemia and impaired spatial vision |
| abstract | Provided are methods of treating hyperglycemia using a STAT3 inhibitor. Also provided is a STAT3 inhibitor for use in treating hyperglycemia. Further provided are methods of treating impaired spatial vision using a STAT3 inhibitor. Also provided is a STAT3 inhibitor for use in treating impaired spatial vision. In certain embodiments, the STAT3 inhibitor is administered systemically. In certain embodiments, the STAT3 inhibitor is administered orally. In certain embodiments, the STAT3 inhibitor is a small molecule. In certain embodiments, the STAT3 inhibitor is 1-acetyl-5 -hydroxyanthracene- 9,10-dione (CLT-005) or a pharmaceutically acceptable salt thereof. Also provided is a pharmaceutical composition comprising CLT-005, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, formulated for oral administration. |
| priorityDate | 2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 201.